Navigation Links
Pfenex Inc. Launches

SAN DIEGO, Nov. 2, 2010 /PRNewswire/ -- Pfenex Inc. today announced the launch of a new business division, Reagent Proteins. Reagent Proteins will enhance the development scientists' ability to source complex reagent grade proteins at a competitive price.

Reagent Proteins will initially offer a product list in excess of 2300 proteins, including stem cell growth factors, cytokines, chemokines, and enzymes. A unique aspect of Reagent Proteins' offering includes vaccine carriers, adjuvants and antigens, available in both pre-clinical and cGMP quality grades. Reagent Proteins is the only protein supplier supporting human vaccine developers from discovery to commercialization with a broad range of vaccine components.

"As we continue to leverage our business based on efficient complex protein production, the Reagent Proteins business unit is an obvious choice," stated Bertrand C. Liang, Chief Executive Officer, "We have and continue to build a portfolio of proteins in areas of need, including those based upon monitoring of industry trends as well as direct feedback from the researchers themselves."

About Reagent Proteins

Reagent Proteins is a leading supplier of reagent, pre-clinical and cGMP grade proteins to the biopharmaceutical and vaccine development community. We ensure that scientists have ready access to a comprehensive offering of high quality proteins to enable their development efforts to proceed efficiently.

About Pfenex Inc.

Pfenex Inc. is a protein production company leveraging the unique and powerful Pfenex Expression Technology™ platform based on the microorganism, Pseudomonas fluorescens, for the production of research proteins, reagent proteins, biosimilars and innovator biopharmaceuticals. For more information please visit

SOURCE Pfenex Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Adaptive TCR Launches the immunoSEQ™ Product Line - Visualizing the Immune System With Next-Generation Sequencing.
2. Prometheus Research Launches Solutions Group to Springboard HTSQL-based Solutions for Customers
3. Davis Phinney Foundation Launches Exercise-Focused Tools to Help People Live Well With Parkinsons Disease
4. CoreLab Partners Launches New DXA Imaging Service Offerings
5. Verenium Launches DELTAZYM® GA L-E5 Enzyme for Fuel Ethanol Production
6. InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010
7. Michael J. Fox Foundation Launches Parkinsons Progression Markers Initiative (PPMI)
8. HelixLife Launches Custom Health Supplements, Anti-Aging and Acne Skin Serums
9. Norgen Biotek Corp. Launches a Novel kit to Collect, Concentrate, Preserve and Isolate DNA, RNA, microRNA and proteins from Urine Specimens
10. Serono Symposia International Foundation (SSIF) Launches a New Web Site Dedicated to Medical Education on Phenylketonuria (PKU)
11. West Michigan Launches $10 Million Early Stage Venture Fund to Support Life Science & Technology
Post Your Comments:
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... While ... machines such as the Cary 5000 and the 6000i models are higher end machines ... is the height of the spectrophotometer’s light beam from the bottom of the cuvette ...
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):